Is 0YAY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0YAY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0YAY (SEK223.98) is trading above our estimate of fair value (SEK223.8)
Significantly Below Fair Value: 0YAY is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0YAY?
Key metric: As 0YAY is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 0YAY. This is calculated by dividing 0YAY's market cap by their current
revenue.
What is 0YAY's PS Ratio?
PS Ratio
8.4x
Sales
SEK 3.56b
Market Cap
SEK 29.98b
0YAY key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 0YAY is expensive based on its Price-To-Sales Ratio (8.4x) compared to the European Biotechs industry average (7.9x).
Price to Sales Ratio vs Fair Ratio
What is 0YAY's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
0YAY PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
8.4x
Fair PS Ratio
3.3x
Price-To-Sales vs Fair Ratio: 0YAY is expensive based on its Price-To-Sales Ratio (8.4x) compared to the estimated Fair Price-To-Sales Ratio (3.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 0YAY forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
SEK 223.98
SEK 273.33
+22.0%
3.4%
SEK 280.00
SEK 260.00
n/a
3
Nov ’25
SEK 234.60
SEK 271.67
+15.8%
3.1%
SEK 280.00
SEK 260.00
n/a
3
Oct ’25
SEK 253.65
SEK 271.67
+7.1%
3.1%
SEK 280.00
SEK 260.00
n/a
3
Sep ’25
SEK 246.76
SEK 261.67
+6.0%
3.9%
SEK 275.00
SEK 250.00
n/a
3
Aug ’25
SEK 231.71
SEK 261.67
+12.9%
3.9%
SEK 275.00
SEK 250.00
n/a
3
Jul ’25
SEK 173.50
SEK 231.67
+33.5%
10.3%
SEK 265.00
SEK 210.00
n/a
3
Jun ’25
SEK 182.60
SEK 231.67
+26.9%
10.3%
SEK 265.00
SEK 210.00
n/a
3
May ’25
SEK 166.30
SEK 231.67
+39.3%
10.3%
SEK 265.00
SEK 210.00
n/a
3
Apr ’25
SEK 200.70
SEK 248.33
+23.7%
6.6%
SEK 270.00
SEK 230.00
n/a
3
Mar ’25
SEK 180.00
SEK 248.33
+38.0%
6.6%
SEK 270.00
SEK 230.00
n/a
3
Feb ’25
SEK 169.35
SEK 241.67
+42.7%
8.7%
SEK 270.00
SEK 220.00
n/a
3
Jan ’25
SEK 194.80
SEK 255.00
+30.9%
7.3%
SEK 280.00
SEK 235.00
n/a
3
Dec ’24
SEK 181.39
SEK 250.00
+37.8%
9.8%
SEK 280.00
SEK 220.00
n/a
3
Nov ’24
SEK 143.08
SEK 256.67
+79.4%
12.9%
SEK 300.00
SEK 220.00
SEK 234.60
3
Oct ’24
SEK 149.05
SEK 281.67
+89.0%
5.1%
SEK 300.00
SEK 265.00
SEK 253.65
3
Sep ’24
SEK 150.32
SEK 281.67
+87.4%
5.1%
SEK 300.00
SEK 265.00
SEK 246.76
3
Aug ’24
SEK 162.33
SEK 281.67
+73.5%
5.1%
SEK 300.00
SEK 265.00
SEK 231.71
3
Jul ’24
SEK 209.75
SEK 315.00
+50.2%
4.7%
SEK 330.00
SEK 295.00
SEK 173.50
3
Jun ’24
SEK 220.12
SEK 321.67
+46.1%
6.0%
SEK 340.00
SEK 295.00
SEK 182.60
3
May ’24
SEK 231.01
SEK 321.67
+39.2%
6.0%
SEK 340.00
SEK 295.00
SEK 166.30
3
Apr ’24
SEK 215.20
SEK 318.33
+47.9%
7.5%
SEK 340.00
SEK 285.00
SEK 200.70
3
Mar ’24
SEK 213.02
SEK 318.33
+49.4%
7.5%
SEK 340.00
SEK 285.00
SEK 180.00
3
Feb ’24
SEK 230.01
SEK 335.00
+45.6%
1.5%
SEK 340.00
SEK 330.00
SEK 169.35
2
Jan ’24
SEK 191.10
SEK 335.00
+75.3%
1.5%
SEK 340.00
SEK 330.00
SEK 194.80
2
Dec ’23
SEK 197.22
SEK 260.00
+31.8%
40.8%
SEK 340.00
SEK 110.00
SEK 181.39
3
Nov ’23
SEK 184.03
SEK 260.00
+41.3%
40.8%
SEK 340.00
SEK 110.00
SEK 143.08
3
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.